Authors: Chizh, BA Reissmuller, E Schlutz, H Scheede, M Haase, G Englberger, W

Citation: Ba. Chizh et al., Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil, NEUROPHARM, 40(2), 2001, pp. 212-220

Authors: Kuhl, U Englberger, W Haurand, M Holzgrabe, U

Citation: U. Kuhl et al., Diazabicyclo[3.3.1]nonanone-type ligands for the opioid receptors, ARCH PHARM, 333(7), 2000, pp. 226-230

Authors: Chizh, BA Schlutz, H Scheede, M Englberger, W

Citation: Ba. Chizh et al., The N-methyl-D-aspartate antagonistic and opioid components of d-methadoneantinociception in the rat spinal cord, NEUROSCI L, 296(2-3), 2000, pp. 117-120

Authors: Siener, T Cambareri, A Kuhl, U Englberger, W Haurand, M Kogel, B Holzgrabe, U

Citation: T. Siener et al., Synthesis and opioid receptor affinity of a series of 2,4-diaryl-substituted 3,7-diazabicylononanones, J MED CHEM, 43(20), 2000, pp. 3746-3751

Authors: Wnendt, S Kruger, T Janocha, E Hildebrandt, D Englberger, W

Citation: S. Wnendt et al., Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay, MOLEC PHARM, 56(2), 1999, pp. 334-338